Evaluation of the potential for pharmacokinetic interaction between tirabrutinib and levonorgestrel/ethinyl estradiol in healthy female volunteers
Abstract Tirabrutinib (TIRA), a potent and nonreversible oral Bruton tyrosine kinase inhibitor, is evaluated for treatment of certain hematological malignancies and inflammatory diseases. A drug-drug interaction study to evaluate the effect of TIRA on the pharmacokinetics of the oral contraceptive l...
Saved in:
Main Authors: | Ganesh Cherala (Author), Cara Nelson (Author), Ying Guo (Author), Anubhav Mathur (Author), Thomas Tarnowski (Author), Ahmed A. Othman (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of the selective AMPA modulator NBI‐1065845 on the pharmacokinetics of midazolam or ethinyl estradiol-levonorgestrel in healthy adults
by: Swan Lin, et al.
Published: (2024) -
The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
by: Rachel A. Bonnema, et al.
Published: (2011) -
New low-dose, extended-cycle pills with levonorgestrel and ethinyl estradiol: an evolutionary step in birth control
by: Anita Nelson
Published: (2010) -
Cycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval
by: Nappi RE, et al.
Published: (2017) -
The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 µg/levonorgestrel 100 µg + ethinyl estradiol 10 µg
by: Sheila Krishnan, et al.
Published: (2010)